174 related articles for article (PubMed ID: 32273944)
1. Redox-Active Drug, MnTE-2-PyP
Barbosa AM; Sarmento-Neto JF; Menezes Filho JER; Jesus ICG; Souza DS; Vasconcelos VMN; Gomes FDL; Lara A; Araújo JSS; Mattos SS; Vasconcelos CML; Guatimosim S; Cruz JS; Batinic-Haberle I; Araújo DAM; Rebouças JS; Gomes ER
Oxid Med Cell Longev; 2020; 2020():4850697. PubMed ID: 32273944
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
3. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
4. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
6. Manganese-porphyrin reactions with lipids and lipoproteins.
Bloodsworth A; O'Donnell VB; Batinic-Haberle I; Chumley PH; Hurt JB; Day BJ; Crow JP; Freeman BA
Free Radic Biol Med; 2000 Apr; 28(7):1017-29. PubMed ID: 10832063
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.
Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
[TBL] [Abstract][Full Text] [Related]
10. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
Gad SC; Sullivan DW; Crapo JD; Spainhour CB
Int J Toxicol; 2013 Jul; 32(4):274-87. PubMed ID: 23704100
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage.
Sheng H; Spasojevic I; Tse HM; Jung JY; Hong J; Zhang Z; Piganelli JD; Batinic-Haberle I; Warner DS
J Pharmacol Exp Ther; 2011 Sep; 338(3):906-16. PubMed ID: 21652782
[TBL] [Abstract][Full Text] [Related]
12. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
[TBL] [Abstract][Full Text] [Related]
13. Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells.
Jaramillo MC; Briehl MM; Crapo JD; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2012 Apr; 52(8):1272-84. PubMed ID: 22330065
[TBL] [Abstract][Full Text] [Related]
14. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
[TBL] [Abstract][Full Text] [Related]
15. Thermal Stability Kinetics and Shelf Life Estimation of the Redox-Active Therapeutic and Mimic of Superoxide Dismutase Enzyme, Mn(III)
Maia CGC; de Araujo BCR; de Freitas-Marques MB; da Costa IF; Yoshida MI; da Nova Mussel W; Sebastião RCO; Rebouças JS
Oxid Med Cell Longev; 2021; 2021():7003861. PubMed ID: 34912497
[TBL] [Abstract][Full Text] [Related]
16. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
Rebouças JS; Spasojević I; Batinić-Haberle I
J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
[TBL] [Abstract][Full Text] [Related]
17. MnTE-2-PyP modulates thiol oxidation in a hydrogen peroxide-mediated manner in a human prostate cancer cell.
Tong Q; Zhu Y; Galaske JW; Kosmacek EA; Chatterjee A; Dickinson BC; Oberley-Deegan RE
Free Radic Biol Med; 2016 Dec; 101():32-43. PubMed ID: 27671770
[TBL] [Abstract][Full Text] [Related]
18. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
[TBL] [Abstract][Full Text] [Related]
19. Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).
Pinto VH; Carvalhoda-Silva D; Santos JL; Weitner T; Fonseca MG; Yoshida MI; Idemori YM; Batinić-Haberle I; Rebouças JS
J Pharm Biomed Anal; 2013 Jan; 73():29-34. PubMed ID: 22503130
[TBL] [Abstract][Full Text] [Related]
20. Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.
Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
J Endourol; 2012 Nov; 26(11):1420-4. PubMed ID: 22783812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
